Listar por autor "Freitas, Caroline S. de"
Mostrando ítems 1-15 de 15
-
2,8-bis (trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine
Lima, Giselle Barbosa et al. | Fecha del documento: 2017 -
Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases
Chaves, Otávio Augusto et al. | Fecha del documento: 2022 -
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
Fintelman-Rodrigues, Natalia et al. | Fecha del documento: 2020 -
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
Fintelman-Rodrigues, Natalia et al. | Fecha del documento: 2020 -
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
Rodrigues, Natalia Fintelman et al. | Fecha del documento: 2020 -
Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin
Sacramento, Carolina Q. et al. | Fecha del documento: 2015 -
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
Sacramento, Carolina Q. et al. | Fecha del documento: 2021 -
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
Dias, Suelen da Silva Gomes et al. | Fecha del documento: 2020 -
N-(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity
Lima, Giselle Barbosa et al. | Fecha del documento: 2017 -
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
Ferreira, André C. et al. | Fecha del documento: 2021 -
Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages
Ferreira, André C. et al. | Fecha del documento: 2023 -
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
Teixeira, Lívia et al. | Fecha del documento: 2022 -
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Sacramento, Carolina Q. et al. | Fecha del documento: 2017 -
VIP plasma levels associate with survival in severe COVID-19 patients, correlatingwith protective effects in SARS-CoV-2-infected cells
Temerozo, Jairo R. et al. | Fecha del documento: 2022 -
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
Freitas, Caroline S. de et al. | Fecha del documento: 2019